152 related articles for article (PubMed ID: 28738453)
41. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
Sun PP; Zhang SX; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
[No Abstract] [Full Text] [Related]
42. Global progress toward universal childhood hepatitis B vaccination, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
[TBL] [Abstract][Full Text] [Related]
43. An ethical argument in favour of routine hepatitis B vaccination in very low-incidence countries.
Dawson AJ
Lancet Infect Dis; 2005 Feb; 5(2):120-5. PubMed ID: 15680782
[TBL] [Abstract][Full Text] [Related]
44. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
45. JCVI response on hepatitis B vaccination.
Joint Committee on Vaccination and Immunisation
Lancet; 2012 Mar; 379(9818):803. PubMed ID: 22386032
[No Abstract] [Full Text] [Related]
46. Immunization strategies for the elimination of hepatitis B.
Reece SM
Nurse Pract; 1993 Feb; 18(2):42-5, 49-50. PubMed ID: 8455811
[TBL] [Abstract][Full Text] [Related]
47. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
[TBL] [Abstract][Full Text] [Related]
48. [A large scale cohort study on the immunization effect of hepatitis B vaccine in Fujian province].
Zhang DJ; Hong RT; Huang LF; Wu RH
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Aug; 39(8):1091-1095. PubMed ID: 30180434
[No Abstract] [Full Text] [Related]
49. [Evaluation of economic outcomes of "hepatitis B vaccine event reported by media" in China, 2013].
Zhang SX; Sun PP; Xia Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Aug; 52(8):837-841. PubMed ID: 30107719
[No Abstract] [Full Text] [Related]
50. Vaccine uptake rather than disease mitigation seems to be aim of universal hepatitis B vaccination in the UK.
Puliyel J
BMJ; 2013 Sep; 347():f5187. PubMed ID: 24004990
[No Abstract] [Full Text] [Related]
51. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
52. The National Task Force on Hepatitis B Immunization, Focus on Asians and Pacific Islanders: a chronicle of achievement.
Reilley BA
Asian Am Pac Isl J Health; 2001; 9(2):112-37. PubMed ID: 11858145
[TBL] [Abstract][Full Text] [Related]
53. Costs of running a universal adolescent hepatitis B vaccination programme.
Wallace LA; Young D; Brown A; Cameron JC; Ahmed S; Duff R; Carman WF; Kitchin NR; Nguyen-Van-Tam JS; Goldberg DJ
Vaccine; 2005 Dec; 23(48-49):5624-31. PubMed ID: 16099079
[TBL] [Abstract][Full Text] [Related]
54. Universal hepatitis B vaccination.
Hahné S; Ramsay M; Coutinho R
Lancet Infect Dis; 2008 Feb; 8(2):87-8; author reply 90. PubMed ID: 18222157
[No Abstract] [Full Text] [Related]
55. [Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China].
Cui FQ; Gong XH; Chen YS
Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):289-93. PubMed ID: 20077723
[TBL] [Abstract][Full Text] [Related]
56. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
57. An update after 16 years of hepatitis B vaccination in South Africa.
Burnett RJ; Kramvis A; Dochez C; Meheus A
Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B in children.
Broderick AL; Jonas MM
Semin Liver Dis; 2003 Feb; 23(1):59-68. PubMed ID: 12616451
[TBL] [Abstract][Full Text] [Related]
59. Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
Beutels P; Edmunds WJ; Antoñanzas F; De Wit GA; Evans D; Feilden R; Fendrick AM; Ginsberg GM; Glick HA; Mast E; Péchevis M; Van Doorslaer EK; van Hout BA;
Pharmacoeconomics; 2002; 20(1):1-7. PubMed ID: 11817988
[TBL] [Abstract][Full Text] [Related]
60. The global impact of vaccination against hepatitis B: a historical overview.
Zanetti AR; Van Damme P; Shouval D
Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
